Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition

Patients with non-small cell lung cancer (NSCLC) with echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) rearrangements generally respond to ALK inhibitors such as crizotinib. However, some patients with EML4-ALK rearrangements respond poorly to crizotinib. Hypo...

Descripción completa

Detalles Bibliográficos
Autores principales: KOGITA, AKIHIRO, TOGASHI, YOSUKE, HAYASHI, HIDETOSHI, SOGABE, SHUNSUKE, TERASHIMA, MASATO, DE VELASCO, MARCO A., SAKAI, KAZUKO, FUJITA, YOSHIHIKO, TOMIDA, SHUTA, TAKEYAMA, YOSHIFUMI, OKUNO, KIYOTAKA, NAKAGAWA, KAZUHIKO, NISHIO, KAZUTO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151805/
https://www.ncbi.nlm.nih.gov/pubmed/25096400
http://dx.doi.org/10.3892/ijo.2014.2574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151805/
https://www.ncbi.nlm.nih.gov/pubmed/25096400
http://dx.doi.org/10.3892/ijo.2014.2574

Ejemplares similares